• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

prostate cancer - Articles and news items

degarelix

NICE says ‘yes’ to degarelix for men with prostate cancer and spinal metastases

Industry news / 1 July 2016 / Victoria White, Digital Content Producer

NICE has recommended Ferring’s Firmagon (degarelix) for men with advanced-hormone dependent prostate cancer and spinal metastases…

myovant

Takeda and Roivant launch Myovant Sciences Ltd

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Myovant Sciences is a biopharmaceutical company focused on delivering innovative women’s health and prostate cancer therapeutics…

BAY-1841788

Bayer and Orion expand BAY-1841788 programme in prostate cancer

Industry news / 3 June 2016 / Victoria White, Digital Content Producer

The Phase III study ARASENS will evaluate BAY-1841788 in men with newly diagnosed metastatic hormone-sensitive prostate cancer…

advanced prostate cancer

NICE recommends Jevtana for advanced prostate cancer

Industry news / 25 May 2016 / Victoria White, Digital Content Producer

Jevtana has been recommended in combination with other drugs as a treatment option for metastatic hormone-relapsed prostate cancer in England…

cabazitaxel

NICE U-turn on cabazitaxel for prostate cancer

Industry news / 22 April 2016 / Victoria White, Digital Content Producer

NICE has issued final guidance recommending Sanofi’s Jevtana (cabazitaxel) for some prostate cancer patients…

Tesaro

Janssen and Tesaro in niraparib collaboration and license agreement

Industry news / 8 April 2016 / Victoria White, Digital Content Producer

Tesaro will receive an upfront payment of $35 million, and is eligible to receive additional milestone payments of up to $415 million…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +